HALO logo
halo search icon
MRK
Merck & Co., Inc.

MRK · Merck & Co., Inc.

131.07

USD
0.59 (0.452%)
24/07/2026 04:10:00 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$322.26B

PE

19.70

EV/EBITDA

12.3

DIV Yield

2.2%

Payout Ratio

44%

MQV Rating

5Very Weak

As at 24/07/2026 04:10:00 PM

Price Chart

Description

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

  • All-Companies
  • All-Consensus
  • ALL-Recommendations
  • HALO 200
  • HALO 500
  • HALO All
  • HALO Price Momentum
  • Hammer Bearish (Realtime)
  • Near 52 Week High
  • Near Resistance
  • Near Resistance (Realtime)
  • Recent Price upgrade
  • Short Term Trend - Long

Key Fundamentals

EPS 3 yr Growth

104.80%

EBITDA Margin

37.90%

Operating Cashflow

$2,056m

Free Cash Flow Return

54.10%

ROIC

46.90%

Interest Coverage

41.60

Quick Ratio

1.00

Performance

52 weeks range

Low 76.66 - 131.74

Trade Value (12mth)

US$308,225,583.00

1 week

2.23%

1 month

8.19%

YTD

22.57%

1 year

55.13%

All time high

134.63

Additional Data

Shares Outstanding (Fully Diluted)

2,405m

HALO Sector

Healthcare

Next Company Report Date

02-Feb-27

Next Ex Dividend Date

15-Jun-26

Next Dividend Pay Date

08-Jul-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Strong

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
25 June 26EDG
25 June 26EDG
25 June 26EDG
25 June 26EDG
25 June 26EDG

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The current share price of Merck & Co., Inc. (MRK:NYS) is USD$131.07.
2
What is the 52-week high share price for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The 52-week high share price for Merck & Co., Inc. (MRK:NYS) is USD$131.74.
3
What is the 52-week low share price for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The 52-week low share price for Merck & Co., Inc. (MRK:NYS) is USD$76.66.
4
What is the dividend yield for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The current TTM dividend payout for Merck & Co., Inc. (MRK:NYS) is 2.20.
5
What was Merck & Co., Inc. (MRK:NYS) last dividend payment?
Halo FAQ
The last dividend payment of Merck & Co., Inc. (MRK:NYS) is USD$0.85.
6
What is the franking level for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
Merck & Co., Inc. (MRK:NYS) has a franking level of 0.00%.
7
In which sector is Merck & Co., Inc. (MRK:NYS) classified?
Halo FAQ
Merck & Co., Inc. (MRK:NYS) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The current P/E ratio for Merck & Co., Inc. (MRK:NYS) is 19.70.